The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

Regeneron Pharmaceuticals has signed a new licensing agreement with Hansoh Pharmaceuticals Group to develop and sell its weight loss therapy outside of China.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Ozempic may affect your face, bowel movements and hair. Check out the Ozempic side effects before taking this anti-diabetes ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

LOOKING at my reflection in the mirror, I felt delighted to see my petite size 8 figure once again. But as I glanced up to my face, the gaunt woman staring back at me came as a shock. After having ...

FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it ...

The weight loss drug Zepbound (tirzepatide) led to 50 percent more weight loss in a 72-week trial than Wegovy (semaglutide). Participants taking Zepbound lost 50 pounds (lb) on average ...

As obesity and type 2 diabetes rates rise globally, innovative treatments like the Mounjaro injection in Dubai. medical professional before starting any new medication or weight loss program.

World Thyroid Day 2025 urges awareness of thyroid disorders, promotes early testing, and highlights treatment and dietary ...

Weight-loss medications known as glucagon-like peptide-1 (GLP-1) agonists, which have gained popularity for treating type 2 diabetes and obesity, have been shown to have the surprising secondary ...